Page 343 - ASHG 2013 Program Guide

324  
SPEAKER AND AUTHOR DISCLOSURES
Pratt, M., Personalis, Inc - 1, 3 (2608F)
Qaadri, K., Biomatters, Inc. - 1 (1631F)
Rahman, N., Illumina - 9, 12 (93)
Ranade, S., Pacific Biosciences - 1, 3 (688F)
Ray, F., KromaTiD Inc. - 1, 3, 4, 5 (3251F)
Raymond, G., Bluebird Bio - 2 (87)
Regan, J., Bio-Rad Laboratories - 3 (549T)
Regev, A., Syros - 1 (Session 77)
Rehm, H. L., Ingenuity - 11; Illumina - 12; Knome - 11;
Complete Genomics; Omicia, BioBase, Clinical
Futures - 11 (Session 70)
Reid, J., DNAnexus - 12 (257)
Rieder, M. J., Adaptive Biotechnologies - 1, 3 (550F)
Roa, B., Myriad Genetic Laboratories, Inc. - 1, 3 (3298T)
Robison, R., Tute Genomics Inc. - 4 (1500W)
Rodriguez, D., New England Biolabs - 3 (1675T)
Rose, S. D., Integrated DNA Technologies - 3 (1664F)
Rothwell, R., National Science Foundation Graduate
Fellowship - 2; Genome Science Training Program -
2 (2093
W)
Rozenfeld, P., Shire HGT - 14 (2400F)
Sapp, J. C., NHGRI - 3 (Session 41)
Schaaf, C. P., Baylor College of Medicine - 3;
Complete Genomics - 3 (325)
Schwartz, S., Laboratory Corporation of America - 1,
3 (167)
Shahmirzadi, L. M., Ambry Genetics - 3 (2629F)
Sharp, R. R., Complete Genomics - 15; Scientific
Advisory Board member, advisory only, no
compensation (Session 41)
Shelton, D. N., Bio-Rad Laboratories - 3; Telome
Health - 13 (3423W)
Shendre, A., NHLBI - 2 (703W)
Skeen, J., Asuragen, Inc. - 1, 3 (2825W)
Small, K. W. S., Molecular Insight Research
Foundation - 13; Cedars-Sinai Regenerative
Medicine Institite - 3; Macula & Retina Institute - 13;
Arctic Dx - Macula Risk - 3 (1064F)
Smith, M. S., Viracor-IBT Laboratories - 1, 3 (1534T)
Smith, S., NIDCD R01DC005226 to Dr. Rice - 2 (1194T)
Soden, S., Illumina - 9 (358)
Sokolsky, T. D., Parabase Genomics, Inc - 3 (2529T)
Solomon, A., Station X, Inc. - 1, 3 (1615T)
Solzak, J. P., Ingenuity Systems - 12 (1507T)
Stevanin, G., ANR - 2; European Union - 2; Verum - 2;
INSERM-DGRSRT Cooperative - 2 (2974F)
Stewart, F. J., Genzyme - 14; Shire - 14; Biomarin - 14;
Amicus - 14 (2379T)
St. Jean, P. L., Arctic Dx - 1, 10 (1163F)
Struble, C., Ariosa Diagnostics, Inc - 1, 3 (2594W)
Suchy, S. F., GeneDx - 3 (3134W)
Susswein, L. R., Courtagen Life Sciences, Inc. - 3 (1345F)
Swergold, G. D., Regeneron Pharmaceuticals, Inc. - 1,
3 (2153
F)
Taft, R. J., Isis Pharmaceuticals - 5 (3009T)
Talasaz, A., Guardant Health - 3, 4 (3478T)
Tan, D., Zymo Research Corp. - 3 (478T)
Tang, S., Ambry Genetics - 3 (1341T)
Tao, H., CardioDx - 3 (2138F)
Tavares, P., CGC Genetics - 3 (2632F)
Taylor, J., Illumina - 12 (388)
Theru Arumugam, S., Cincinnati Children’s Hospital
Medical Center - 3 (2530F)
Tim, R. C., Sequenom, Inc. - 1 (2850T)
Toloue, M., Bioo Scientific - 1, 3 (1676F)
Tome, S., Prosensa - 5, 11 (1406W)
Toro, J. R., GeneDx, BioReference Laboratories, Inc. -
3 (3361
T)
Tung, J. Y., 23andMe, Inc. - 1, 3 (958T)
Tynan, J., Sequenom - 1, 3 (2866T)
van den Akker, E. B., Rinat-Pfizer Inc - 1, 2, 3, 12 (1148F)
Vandenberghe, L. H., GenSight Biologics - 1, 4, 5, 6;
ReGenX Biosciences - 10, 11; Novartis Institutes of
Biomedical Research - 5; Avalanche Biotechnology -
11 (
Session 3)
Vidal, M., Proteostasis Therapeutics, Inc. - 11
(
Session 77)
Virata, M., Illumina - 1, 3 (1655F)
Vissers, L., Complete Genomics - 3 (3083W)
Walker, J., Fluidigm Corp - 3 (1639T)
Wang, E., Ariosa Diagnostics, Inc - 1, 3 (2586T)
Wang, J., Quest Diagnostics - 3 (3254T)
Wang, K., Foundation Medicine - 1, 3 (3332F)
Wang, X., Fluidigm inc - 1, 3 (1659W)
Wang, X. Y., BD Biosciences - 3; Illumina - 3 (1661F)
Wang, Y., AncestryDNA - 3 (1974T)
Warren, L., GSK - 1, 3 (372)
Wassman, E. R., Rosetta Genomics - 1, 3 (3501W)
Weaver, D., Genformatic - 3, 4, 5, 10 (1516T)
Weitzel, J., Life Sciences - 9 (3321W)
Wilson, S. G., NHMRC (Project No. 1048216) - 2 (1109F)
Wingrove, J., CardioDx, Inc. - 3 (2139W)
Wolf, L., FDNA ltd. - 3, 4, 5 (2670W)
Wong, S., Eli Lilly and Company - 3 (3448T)
Xue, Y., Genzyme - 3 (2273T)
Yano, S., Genzyme - 2 (83)
Yasuda, M., Alnylam Pharmaceuticals - 2, 5 (2306F)
Yaykasli, K. O., TUBITAK, Project No:SBAG/111S218 -
2 (2317
T)
Yokoi, T., Hitachi, Ltd. - 3 (2588W)
Yrigollen, C., Asuragen Inc. - 12 (1401T)
Zai, C. C., Eli Lilly Canada - 2; GSK - 2 (763T)
Zhou, H., Merck - 1, 3 (663T)
Zimran, A., Protalix Biotherapeutics - 1, 5, 6; Shire Human
Genetic Therapies - 5, 8; Pfizer - 5, 8 (Session 42);
Shire - 2, 3, 14; Protalix Biotherapeutics - 11; Pfizer -
14;
Genzyme - 2 (2389T)
Zode, G., Alcon Labs - 2 (2281T)